EBR Systems, Inc. Appoints Dr. Rick Kuntz as Consulting Chief Scientific Officer
February 21, 2023 at 05:12 pm EST
Share
EBR Systems, Inc. announced that it has appointed Dr. Rick Kuntz as consulting Chief Scientific Officer. Dr. Kuntz has a broad background and expertise in many different areas of healthcare. He previously served
as Senior Vice President, Chief Medical and Scientific Officer of Medtronic overseeing medical affairs, health policy, reimbursement, clinical research activities and corporate technology. In addition, he was the Founder
and Chief Scientific Officer of the Harvard Research Institute (HCRI), a university-based contract research organisation which coordinates National Institutes of Health (NIH) and clinical trials with the United States Food
and Drug Administration (FDA). Over his career, Dr. Kuntz has directed numerous multicentre clinical trials and has authored more than 250 original publications. He graduated from Miami University and received his medical degree from Case Western Reserve University School of Medicine. He also completed fellowships in cardiovascular diseases and interventional cardiology at the Beth Israel Hospital and Harvard Medical School. He has received his Master of Science and Biostatistics from the Harvard School of Public Health.
EBR Systems, Inc. is engaged in the treatment for patients suffering from cardiac rhythm diseases by providing physiological stimulation through endocardiac pacing. The Company is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The Company also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The Company operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.
EBR SYSTEMS, INC. 
